Susanne Bro Selected Research

Enalapril

11/2009	Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
1/2008	Cardiac structure and function in a mouse model of uraemia without hypertension.
5/2007	Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne Bro Research Topics

Disease

10	Atherosclerosis 10/2010 - 10/2003
9	Uremia 10/2010 - 10/2003
4	Chronic Renal Insufficiency 02/2024 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2003
4	Chronic Kidney Failure (Chronic Renal Failure) 03/2009 - 10/2003
2	Inflammation (Inflammations) 12/2008 - 10/2007
1	Vascular Calcification 12/2023
1	Bone Diseases (Bone Disease) 12/2023
1	Diabetes Mellitus 12/2023
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 12/2023
1	Kidney Diseases (Kidney Disease) 01/2018
1	Atherosclerotic Plaque (Atheroma) 10/2010
1	Aortic Valve Disease 03/2009
1	Fibrosis (Cirrhosis) 01/2008
1	Body Weight (Weight, Body) 01/2008
1	Hypertension (High Blood Pressure) 01/2008
1	Hypercholesterolemia 03/2006

Drug/Important Bio-Agent (IBA)

10	ApolipoproteinsIBA 08/2010 - 10/2003
8	Apolipoproteins E (ApoE)IBA 08/2010 - 03/2006
4	oxidized low density lipoproteinIBA 01/2022 - 10/2007
4	salicylhydroxamic acid (SHAM)IBA 01/2008 - 06/2004
3	CalciumIBA 01/2023 - 12/2020
3	CreatinineIBA 01/2018 - 10/2007
3	Enalapril FDA LinkGeneric 11/2009 - 05/2007
2	Apolipoproteins B (ApoB)IBA 10/2010 - 08/2010
2	Lipoproteins (Lipoprotein)IBA 10/2010 - 10/2007
2	Phospholipids (Phosphatides)FDA LinkGeneric 10/2010 - 11/2009
2	AntibodiesIBA 08/2010 - 11/2009
2	Receptor for Advanced Glycation End ProductsIBA 11/2009 - 12/2008
2	CholesterolIBA 11/2009 - 12/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2009 - 01/2008
2	Messenger RNA (mRNA)IBA 12/2008 - 01/2008
1	Biomarkers (Surrogate Marker)IBA 02/2024
1	activin AIBA 12/2023
1	omega-Chloroacetophenone (Mace)IBA 12/2023
1	LipidsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Apolipoproteins MIBA 01/2018
1	Apolipoprotein B-100 (Apo B 100)IBA 10/2010
1	1-penicillamyl-Leu(2)- oxytocinIBA 10/2010
1	Apolipoproteins AIBA 10/2010
1	Lipoprotein(a)IBA 10/2010
1	Immunoglobulin G (IgG)IBA 08/2010
1	Peptides (Polypeptides)IBA 08/2010
1	HomocysteineIBA 11/2009
1	EpitopesIBA 11/2009
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 02/2009
1	Neutralizing AntibodiesIBA 12/2008
1	ProcollagenIBA 01/2008
1	BiglycanIBA 01/2008
1	Urea (Carbamide)FDA LinkGeneric 10/2007
1	HDL CholesterolIBA 10/2007
1	Cholic AcidIBA 10/2007
1	Losartan (Cozaar)FDA LinkGeneric 05/2007
1	Vasodilator Agents (Vasodilators)IBA 05/2007
1	Angiotensin Receptor AntagonistsIBA 05/2007
1	Hydralazine (Apresoline)FDA LinkGeneric 05/2007
1	OsteopontinIBA 03/2006
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2004
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2004
1	Parathyroid Hormone (Parathormone)IBA 06/2003
1	calcium phosphateIBA 06/2003

Therapy/Procedure

7	Nephrectomy 10/2010 - 06/2004
1	Therapeutics 11/2009
1	Intraperitoneal Injections 12/2008